CoChat

Methylation-Based Therapies for Colorectal Cancer

Open access
Cervena, Klara, Siskova, Anna, Buchler, Tomas, Vodicka, Pavel, Vymetalkova, Veronika · 2020 · Cells

The DOI matches its Crossref record; 236 of the 241 references it cites were found in a registry or an index.

Abstract

Colorectal carcinogenesis (CRC) is caused by the gradual long-term accumulation of both genetic and epigenetic changes. Recently, epigenetic alterations have been included in the classification of the CRC molecular subtype, and this points out their prognostic impact. As epigenetic modifications are reversible, they may represent relevant therapeutic targets. DNA methylation, catalyzed by DNA methyltransferases (DNMTs), regulates gene expression. For many years, the deregulation of DNA methylation has been considered to play a substantial part in CRC etiology and evolution. Despite considerable advances in CRC treatment, patient therapy response persists as limited, and their profit from systemic therapies are often hampered by the introduction of chemoresistance. In addition, inter-individual changes in therapy response in CRC patients can arise from their specific (epi)genetic compositions. In this review article, we summarize the options of CRC treatment based on DNA methylation status for their predictive value. This review also includes the therapy outcomes based on the patient’s methylation status in CRC patients. In addition, the current challenge of research is to develop therapeutic inhibitors of DNMT. Based on the essential role of DNA methylation in CRC development, the application of DNMT inhibitors was recently proposed for the treatment of CRC patients, especially in patients with DNA hypermethylation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells9061540

Cites

236 of 236 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Consensus molecular subtypes (CMS) classification as proposed by Guinney et al. [131].
Figure 1 Consensus molecular subtypes (CMS) classification as proposed by Guinney et al. [131].CC BY · PubMed Central
Figure 2 (A) Azacitidine, (B) decitabine, (C) guadecitabine, (D) temozolomide.
Figure 2 (A) Azacitidine, (B) decitabine, (C) guadecitabine, (D) temozolomide.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 1

  1. Vaiserman, A.M. (2017). Epigenetics of Aging and Longevity, Academic Press. [1st ed.].

Cited by

See all 60

Metadata

Authors
Cervena, K., Siskova, A., Buchler, T., Vodicka, P., & Vymetalkova, V.
Affiliations
  • Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Videnska 1083, 14 200 Prague, Czech Republic
  • Charles University (CZ)
  • Department of Oncology, First Faculty of Medicine, Charles University and Thomayer Hospital, Videnska 800, 140 59 Prague, Czech Republic
Corresponding author
Vymetalkova, Veronika
Venue
Cells
Publisher
MDPI AG
Published
2020-06-24
Volume
9
Issue
6
Pages
1540
ISSN
2073-4409 (ISSN-L)
OpenAlex
W3038126636
Cited by
57
References
241
Citations by year
2026: 3 · 2025: 11 · 2024: 16 · 2023: 7 · 2022: 11 · 2021: 5 · 2020: 4
FWCI
0.65
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Grant Agency of the Ministry of Health of the Czech Republic (AZV 17-30920A and NV19-09-00237)
  • Charles University Research Centre (UNCE/MED/006)
  • Grant Agency of the Charles University (GAUK 302119)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Keywords
colorectal cancer, DNA methylation, DNA methyltransferases, DNMT inhibitors, epigenetic therapy, DNA hypermethylation, chemoresistance, predictive biomarkers, molecular subtypes, epigenetic modifications
MeSH terms
Humans, Colorectal Neoplasms, DNA Methylation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.